Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction PHILADELPHIA, PA / ACCESS Newswire / ...

BioLizard has supported the development of novel biomarker programs, contributed to AI-driven drug discovery efforts, and ...

Arcus Biosciences stock plunged Friday, reversing a nearly 300% gain, after its Gilead Sciences-partnered cancer regimen ...

Liam Neeson narrates a new documentary that expresses skepticism toward vaccines and includes discredited science. After ...

Of the 3M SF of lab space construction in progress in the metro area, more than half is either build-to-suit in or has some ...

One popular biotech ETF was up about 1% after the Federal Reserve announced its third interest-rate cut for the year. The Federal Reserve cut interest rates as expected - but for the biotech sector, ...

Liam Neeson “never has been, and is not, anti-vaccination,” a representative for the actor told Entertainment Weekly amid controversy over Neeson’s participation in the documentary “Plague of ...

Arcus will now refocus its efforts outside of TIGIT, specifically on its asset casdatifan, an HIF-2a inhibitor once backed by Gilead, as well as its earlier stage small-molecule inflammatory and ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

Fox News senior medical analyst Dr. Marc Siegel joins 'America's Newsroom' to discuss a potential fentanyl vaccine from ARMR ...

Citius Oncology entered into an exclusive distribution agreement with Er-Kim to expand international access to Lymphir (denileukin diftitox-cxdl) in Turkey, Bahrain, Qatar, Oman, Kuwait, Saudi Arabia ...

Is a new obesity drug making people lose too much weight? Plus catch up on #ASH25 and hear how the country's scientific ...